KELSIE REECE: Open Payments
NPI 1275250235 · AMERICAN FORK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 22 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $17 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| SCPHARMACEUTICALS INC. | 1 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $15 |
Products named: VYNDAQEL, LEQVIO, ELIQUIS, CAPVAXIVE, FUROSCIX, AMVUTTRA, Kerendia, UPTRAVI.
Industry payments across UT — which companies pay providers there.
